🇺🇸 Oxaliplatin for injection in United States

49 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Myelosuppression — 13 reports (26.53%)
  2. Neuropathy Peripheral — 6 reports (12.24%)
  3. Lethargy — 5 reports (10.2%)
  4. Anaphylactic Shock — 4 reports (8.16%)
  5. Diarrhoea — 4 reports (8.16%)
  6. Dyspnoea — 4 reports (8.16%)
  7. Nausea — 4 reports (8.16%)
  8. Epistaxis — 3 reports (6.12%)
  9. Hypokalaemia — 3 reports (6.12%)
  10. Hypotension — 3 reports (6.12%)

Source database →

Other Oncology approved in United States

Frequently asked questions

Is Oxaliplatin for injection approved in United States?

Oxaliplatin for injection does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Oxaliplatin for injection in United States?

Shanghai Junshi Bioscience Co., Ltd. is the originator. The local marketing authorisation holder may differ — check the official source linked above.